Anti-Malaria Antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-181)
Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-malaria antigen and anti-TLR1 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.
There are currently no customer reviews or questions for Anti-Malaria Antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) (BSIG-181). Click the button below to contact us or submit your feedback about this product.